“Ceftolozane-Tazobatam for Febrile Neutropenia Treatment in Hematologic Malignancy Patients Colonized by Multi-Resistant Enterobacteriaceae: Preliminary Results from a Prospective Cohort Study: Ceftolozane-Tazobatam for Febrile Neutropenia”. Mediterranean Journal of Hematology and Infectious Diseases, vol. 12, no. 1, Aug. 2020, p. e2020065, https://doi.org/10.4084/mjhid.2020.065.